FTC Denies Sharing Confidential Information in Watson Pharmaceuticals, Inc. Spat

Reuters -- U.S. antitrust enforcers firmly denied on Thursday sharing any confidential information while investigating a deal between Cephalon and Watson Pharmaceuticals to determine if it broke antitrust law.

MORE ON THIS TOPIC